VRNA: Verona Pharma plc - American Depositary Shares

VRNA News

• 19:59 Verona Pharma stock hits all-time high at 105.86 USD
• 13:37 Verona Pharma stock reaches all-time high at 105.54 USD
• 10:50 M&A Transactions In July Included Largest Deal Of 2025
• 04:30 Artisan Global Equity Fund Q2 2025 Commentary
• 16:00 All You Need to Know About Verona Pharma (VRNA) Rating Upgrade to Buy
• 15:32 Merck's Narrowed 2025 Sales View: What it Means After Q2 Results?
• 13:17 Merck Stock Down 4% Since Q2 Results: How to Play the Stock
• 11:14 Wells Fargo lowers Rapt Therapeutics stock price target to $38 on model changes
• 04:21 Verona Pharma ADR earnings beat by $0.11, revenue topped estimates
• 11:27 Ligand Q2 2025 presentation: 57% royalty growth drives raised guidance
• 10:09 Clear Street raises Rapt Therapeutics stock price target to $24 on RPT904 potential
• 00:51 Verona Pharma (VRNA) director Ackermann sells $24k in shares
• 00:49 Verona Pharma CFO Hahn sells $2.75 million in shares
• 00:43 Verona Pharma (VRNA) director Deschamps sells $124,391 in shares
• 00:40 Verona Pharma director Cunningham sells shares for $142,057
• 10:22 Janus Henderson Global Life Sciences Diversified ADR Managed Account Q2 2025 Commentary
• 16:07 Janus Henderson Venture Fund Q2 2025 Commentary
• 11:27 Putnam Large Cap Growth Fund Q2 2025 Commentary
• 10:20 Janus Henderson Global Life Sciences Fund Q2 2025 Commentary (Mutual Fund:JAGLX)
• 09:25 Putnam Small Cap Growth Fund Q2 2025 Commentary
• 13:10 ClearBridge Small Cap Fund Q2 2025 Commentary
• 12:39 Investing $2,000 in Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth Nearly $135,000 Today
• 14:08 Volatility-Proof Your Portfolio With VIPS, GDS, FUTU & VRNA Stocks
• 12:47 Merck Unveils Cost-Cutting Plan: Can it Create Long-Term Value?